greeksoup/ stock research
Stock research / United States / RDY / Planned sales

Dr. Reddy’s Laboratories Limited planned insider sales

In the last twelve months insiders at Dr. Reddy’s Laboratories Limited filed 1 Form 144 notice of planned sales, 460,726 shares worth $6.5 million at the time of filing, from 1 seller. The latest, filed 2 November 2026: Erez Israeli (CEO), 460,726 shares worth $6.5 million, planned for around 29 October 2026 through MERRILL LYNCH.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
2 November 2026Erez IsraeliCeo460,726$6.5 million29 October 2026None on Form 4 yetMERRILL LYNCHSTOCK OPTIONSForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?